{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,7]],"date-time":"2026-06-07T01:00:51Z","timestamp":1780794051229,"version":"3.54.1"},"reference-count":20,"publisher":"American Society of Hematology","issue":"7","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2021,4,13]]},"abstract":"<jats:title>Key Points<\/jats:title>\n               <jats:p>Children with Down syndrome develop early signs of clonal evolution that resemble traditional clonal hematopoiesis. Children with trisomy 21 who exhibit clonal hematopoiesis display cytokine and gene expression profiles indicative of disrupted immunity.<\/jats:p>","DOI":"10.1182\/bloodadvances.2020003858","type":"journal-article","created":{"date-parts":[[2021,3,31]],"date-time":"2021-03-31T15:46:49Z","timestamp":1617205609000},"page":"1791-1796","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":17,"title":["Precocious clonal hematopoiesis in Down syndrome is accompanied by immune dysregulation"],"prefix":"10.1182","volume":"5","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6152-8456","authenticated-orcid":false,"given":"L. Alexander","family":"Liggett","sequence":"first","affiliation":[{"name":"Division of Hematology\/Oncology, Boston Children\u2019s Hospital, and"},{"name":"Department of Pediatric Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA;"},{"name":"Broad Institute of Massachusetts Institute of Technology and Harvard, Cambridge, MA; and"},{"name":"Linda Crnic Institute for Down Syndrome,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0485-3927","authenticated-orcid":false,"given":"Matthew D.","family":"Galbraith","sequence":"additional","affiliation":[{"name":"Linda Crnic Institute for Down Syndrome,"},{"name":"Department of Pharmacology,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2672-6339","authenticated-orcid":false,"given":"Keith P.","family":"Smith","sequence":"additional","affiliation":[{"name":"Linda Crnic Institute for Down Syndrome,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kelly D.","family":"Sullivan","sequence":"additional","affiliation":[{"name":"Linda Crnic Institute for Down Syndrome,"},{"name":"Section of Developmental Biology, Department of Pediatrics,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ross E.","family":"Granrath","sequence":"additional","affiliation":[{"name":"Linda Crnic Institute for Down Syndrome,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Belinda","family":"Enriquez-Estrada","sequence":"additional","affiliation":[{"name":"Linda Crnic Institute for Down Syndrome,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4861-930X","authenticated-orcid":false,"given":"Kohl T.","family":"Kinning","sequence":"additional","affiliation":[{"name":"Linda Crnic Institute for Down Syndrome,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7519-2180","authenticated-orcid":false,"given":"Jessica R.","family":"Shaw","sequence":"additional","affiliation":[{"name":"Linda Crnic Institute for Down Syndrome,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1150-3976","authenticated-orcid":false,"given":"Angela L.","family":"Rachubinski","sequence":"additional","affiliation":[{"name":"Linda Crnic Institute for Down Syndrome,"},{"name":"Section of Developmental Pediatrics, Department of Pediatrics,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9048-1941","authenticated-orcid":false,"given":"Joaquin M.","family":"Espinosa","sequence":"additional","affiliation":[{"name":"Linda Crnic Institute for Down Syndrome,"},{"name":"Department of Pharmacology,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1287-1976","authenticated-orcid":false,"given":"James","family":"DeGregori","sequence":"additional","affiliation":[{"name":"Linda Crnic Institute for Down Syndrome,"},{"name":"Department of Biochemistry and Molecular Genetics,"},{"name":"Department of Immunology and Microbiology,"},{"name":"Section of Pediatric Hematology\/Oncology\/Bone Marrow Transplantation, Department of Pediatrics, and"},{"name":"Section of Hematology, Department of Medicine, University of Colorado Anschutz Medical Campus, Aurora, CO"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","published-online":{"date-parts":[[2021,3,31]]},"reference":[{"issue":"6465","key":"2021033115462420000_B1","doi-asserted-by":"crossref","first-page":"eaan4673","DOI":"10.1126\/science.aan4673","article-title":"Clonal hematopoiesis in human aging and disease","volume":"366","author":"Jaiswal","year":"2019","journal-title":"Science"},{"issue":"7","key":"2021033115462420000_B2","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1038\/s41416-019-0721-1","article-title":"Cancer as a disease of old age: changing mutational and microenvironmental landscapes","volume":"122","author":"Laconi","year":"2020","journal-title":"Br J Cancer"},{"issue":"1","key":"2021033115462420000_B3","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1038\/s41572-019-0143-7","article-title":"Down syndrome","volume":"6","author":"Antonarakis","year":"2020","journal-title":"Nat Rev Dis Primers"},{"issue":"6","key":"2021033115462420000_B4","doi-asserted-by":"crossref","first-page":"2128","DOI":"10.1182\/blood-2007-01-069542","article-title":"Incidence and clinical implications of GATA1 mutations in newborns with Down syndrome","volume":"110","author":"Pine","year":"2007","journal-title":"Blood"},{"issue":"1-2","key":"2021033115462420000_B5","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1615\/CritRevOncog.v16.i1-2.40","article-title":"Myeloid leukemia in Down syndrome","volume":"16","author":"Khan","year":"2011","journal-title":"Crit Rev Oncog"},{"issue":"2","key":"2021033115462420000_B6","doi-asserted-by":"crossref","first-page":"139","DOI":"10.3109\/08880019209018329","article-title":"Leukemia in Down syndrome: a review","volume":"9","author":"Zipursky","year":"1992","journal-title":"Pediatr Hematol Oncol"},{"issue":"9","key":"2021033115462420000_B7","doi-asserted-by":"crossref","first-page":"2977","DOI":"10.1534\/g3.119.400438","article-title":"FERMI: A novel method for sensitive detection of rare mutations in somatic tissue","volume":"9","author":"Liggett","year":"2019","journal-title":"G3 (Bethesda)"},{"key":"2021033115462420000_B8","doi-asserted-by":"crossref","DOI":"10.1182\/blood-2018-99-120168","article-title":"The clonal hematopoietic spectrum of Down syndrome and ML-DS [abstract]","volume":"132","author":"Tong","year":"2018","journal-title":"Blood"},{"issue":"1","key":"2021033115462420000_B9","doi-asserted-by":"crossref","first-page":"12484","DOI":"10.1038\/ncomms12484","article-title":"Clonal haematopoiesis harbouring AML-associated mutations is ubiquitous in healthy adults","volume":"7","author":"Young","year":"2016","journal-title":"Nat Commun"},{"issue":"9","key":"2021033115462420000_B10","doi-asserted-by":"crossref","first-page":"4054","DOI":"10.4049\/jimmunol.1400158","article-title":"TCR bias and affinity define two compartments of the CD1b-glycolipid-specific T cell repertoire","volume":"192","author":"Van Rhijn","year":"2014","journal-title":"J Immunol"},{"issue":"1","key":"2021033115462420000_B11","doi-asserted-by":"crossref","first-page":"30779","DOI":"10.1038\/srep30779","article-title":"Fibroblast growth factor-2 facilitates the growth and chemo-resistance of leukemia cells in the bone marrow by modulating osteoblast functions","volume":"6","author":"Sugimoto","year":"2016","journal-title":"Sci Rep"},{"issue":"5","key":"2021033115462420000_B12","first-page":"465","article-title":"Identification of novel functional variants of SIN3A and SRSF1 among somatic variants in acute myeloid leukemia patients","volume":"41","author":"Min","year":"2018","journal-title":"Mol Cells"},{"issue":"7","key":"2021033115462420000_B13","first-page":"347","article-title":"TAX1BP1, a ubiquitin-binding adaptor protein in innate immunity and beyond","volume":"36","author":"Verstrepen","year":"2011","journal-title":"Trends Biochem Sci"},{"issue":"2","key":"2021033115462420000_B14","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1007\/s11033-011-0835-x","article-title":"The expression of damage-regulated autophagy modulator 2 (DRAM2) contributes to autophagy induction","volume":"39","author":"Yoon","year":"2012","journal-title":"Mol Biol Rep"},{"key":"2021033115462420000_B15","doi-asserted-by":"crossref","first-page":"e16220","DOI":"10.7554\/eLife.16220","article-title":"Trisomy 21 consistently activates the interferon response","volume":"5","author":"Sullivan","year":"2016","journal-title":"eLife"},{"issue":"48","key":"2021033115462420000_B16","doi-asserted-by":"crossref","first-page":"24231","DOI":"10.1073\/pnas.1908129116","article-title":"Trisomy 21 dysregulates T cell lineages toward an autoimmunity-prone state associated with interferon hyperactivity","volume":"116","author":"Araya","year":"2019","journal-title":"Proc Natl Acad Sci USA"},{"issue":"1","key":"2021033115462420000_B17","doi-asserted-by":"crossref","first-page":"34","DOI":"10.2174\/18715273113126660184","article-title":"The Akt-mTOR pathway in Down\u2019s syndrome: the potential use of rapamycin\/rapalogs for treating cognitive deficits","volume":"13","author":"Troca-Mar\u00edn","year":"2014","journal-title":"CNS Neurol Disord Drug Targets"},{"issue":"2","key":"2021033115462420000_B18","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/j.bbamcr.2013.10.015","article-title":"Vascular endothelial growth factor-C modulates proliferation and chemoresistance in acute myeloid leukemic cells through an endothelin-1-dependent induction of cyclooxygenase-2","volume":"1843","author":"Hua","year":"2014","journal-title":"Biochim Biophys Acta"},{"issue":"1","key":"2021033115462420000_B19","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1038\/ni875","article-title":"IFN-lambdas mediate antiviral protection through a distinct class II cytokine receptor complex","volume":"4","author":"Kotenko","year":"2003","journal-title":"Nat Immunol"},{"issue":"1","key":"2021033115462420000_B20","doi-asserted-by":"crossref","first-page":"4766","DOI":"10.1038\/s41467-019-12739-9","article-title":"Trisomy 21 activates the kynurenine pathway via increased dosage of interferon receptors","volume":"10","author":"Powers","year":"2019","journal-title":"Nat Commun"}],"container-title":["Blood Advances"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/ashpublications.org\/bloodadvances\/article-pdf\/5\/7\/1791\/1804083\/advancesadv2020003858.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/ashpublications.org\/bloodadvances\/article-pdf\/5\/7\/1791\/1804083\/advancesadv2020003858.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,3,31]],"date-time":"2021-03-31T15:47:11Z","timestamp":1617205631000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article\/5\/7\/1791\/475593\/Precocious-clonal-hematopoiesis-in-Down-syndrome"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3,31]]},"references-count":20,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2021,4,13]]}},"URL":"https:\/\/doi.org\/10.1182\/bloodadvances.2020003858","relation":{},"ISSN":["2473-9529","2473-9537"],"issn-type":[{"value":"2473-9529","type":"print"},{"value":"2473-9537","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,3,31]]}}}